Antacid
Zantac
Ranitidine and nizatidine, known respectively by their brand names Zantac and Axid, are commonly used drugs to treat heartburn, gastroesophageal reflux disease (GERD), and other stomach ulcer diseases.
Earlier this year, an online pharmacy reported that they detected N-nitrosodimethylamine (NDMA) in ranitidine drugs on the U.S. market. After a preliminary investigation, the Food and Drug Administration (FDA) called for voluntary recalls of both ranitidine and nizatidine drugs that had unsafe levels of NDMA.
1980s
Heartburn, GERD, stomach ulcer diseases
Exposure to NDMA
Get our reporting in your inbox
Read more about Zantac
Zantac Manufacturer Settles Ahead of Bellwether Trial
MedTruth Editors · October 24, 2023
A Zantac case against GlaxoSmithKline alleging the heartburn drug causes cancer has been settled before it went to trial.
Legal DevelopmentsZantac Makers Face New Lawsuit in Connecticut
MedTruth Editors · September 13, 2023
Plaintiffs allege that they developed bladder, breast, prostate or other cancers because of long-term usage of Zantac or its generic, over-the-counter equivalent ranitidine.
Legal DevelopmentsFirst Zantac Lawsuit Trial Date Set, Again
MedTruth Editors · July 28, 2023
The plaintiffs allege that Zantac caused them to develop cancer of nine different types, including colorectal, breast, and bladder cancer.
Legal DevelopmentsGSK Settles Ahead Of First Zantac Trial
MedTruth Editors · July 3, 2023
An individual who claimed to have developed bladder cancer due to the heartburn medication Zantac has reached a settlement with the manufacturer of the drug.
Legal DevelopmentsTens of Thousands of Zantac Cases Pending in State Courts
MedTruth Editors · June 14, 2023
Over 50,000 Zantac lawsuits have been dismissed, with over 100,000 still pending. The cases claim the drug’s active ingredient, ranitidine, causes cancer.
Legal DevelopmentsZantac Class Action Dismissed in Canada
MedTruth Editors · May 26, 2023
The court ruled that the plaintiff lacked the evidence necessary to convince the court that ranitidine, the active ingredient in Zantac, showed any causation to cancer.
Legal DevelopmentsCalifornia Judge Approves Expert Witness in Zantac Trial
MedTruth Editors · April 12, 2023
The ruling will allow a lawsuit by a California resident, who claims he developed bladder cancer because of Zantac, to move forward in a state court.
Legal DevelopmentsCalifornia Bellwether Zantac Trial Delayed Until July
MedTruth Editors · March 8, 2023
The judge overseeing this Zantac case is still deliberating over what expert testimony to admit.
Legal DevelopmentsCA Zantac Trial Awaits Expert Witness Admission
MedTruth Editors · March 3, 2023
The outcome of the case will be heavily influenced by which expert testimony Judge Grillo allows.
Legal DevelopmentsGeneric Zantac Makers Push for MDL Claims Tossed
MedTruth Editors · February 8, 2023
Generic makers of the heartburn drug Zantac are asking the judge to issue a final judgment that would toss out claims against them in the MDL.
Legal DevelopmentsZantac Cancer MDL Dismissed
MedTruth Editors · January 4, 2023
Zantac manufacturers have been cleared from liability in causing plaintiffs’ various types of cancers.
Legal DevelopmentsZantac Cancer Class Action Dismissed
MedTruth Editors · November 30, 2022
The Plumbers & Pipefitters Local Union alleged that Zantac contained a carcinogenic substance, and as a result, the heartburn drug manufacturers should be forced to pay monetary damages.
Legal DevelopmentsZantac Plaintiffs File Expedited Motion Over New Cancer Study
MedTruth Editors · October 18, 2022
Plaintiffs seek permission to file a report that includes data from a study that suggests ranitidine is associated with four different types of cancer.
Legal DevelopmentsZantac MDL Splits Plaintiffs Based on Cancer Type
MedTruth Editors · October 14, 2022
Depending on what type of cancer plaintiffs have, they will either be tried at the state or federal level.
Legal DevelopmentsZantac Expert Testimony Hearings To Be Held
MedTruth Editors · September 27, 2022
These special hearings will determine which expert witnesses will be allowed to testify in the Zantac trials.
Legal DevelopmentsFirst Zantac Trial Ends in Settlement
MedTruth Editors · August 31, 2022
Joseph Bayer agreed to drop his lawsuit, which was scheduled to be held in an Illinois state court, after reaching a settlement of more than $500,000 with generic makers of Zantac.
Legal DevelopmentsZantac Bellwether Dates Set in CA
MedTruth Editors · July 6, 2022
The first four Zantac trials in California have been set for 2023. Zantac users claim that they were unknowingly exposed to unsafe levels of NDMA.
Legal DevelopmentsCA State Court Hears Zantac Lawsuits in October
MedTruth Editors · March 2, 2022
California will hold the first Zantac lawsuits in October of this year. Defendants are accused of failing to warn users about the drug's potential link to cancer.
Legal DevelopmentsJudge Blocks Discovery Request in Zantac Lawsuit
MedTruth Editors · February 15, 2022
GlaxoSmithKline will not be able to subpoena documents from plaintiffs in the Zantac multidistrict litigation.
Legal DevelopmentsBranded Zantac Makers Can’t Escape Class-Action, Judge Rules
MedTruth Editors · October 21, 2021
Zantac manufacturers are facing lawsuits filed by individuals who claim the drug causes cancer.
Legal DevelopmentsDates Set for First Zantac Trials in the Nation
MedTruth Editors · September 29, 2021
The first Zantac cancer case has been scheduled for 2022.
Legal DevelopmentsZantac MDL Judge Reduces Relevant Defendants
MedTruth Editors · August 17, 2021
Judge Rosenberg determined that the lawsuits against the generic manufacturer are preempted since the law does not allow the generics to be labeled differently.
Legal DevelopmentsDrug Companies Investigated for Possible Failure to Disclose Zantac Cancer Risks
MedTruth Editors · September 1, 2020
The U.S. Department of Justice is investigating whether drugmakers violated the False Claims Act by possibly failing to disclose the presence of NDMA in their Zantac and generic ranitidine heartburn products.
NewsCalifornia Attorneys Seek to Consolidate Zantac Lawsuits
James Parker · June 12, 2020
Attorneys representing 40 plaintiffs in California have recently filed a petition to consolidate product liability cases against the manufacturers of the heartburn medication Zantac, which may cause cancer.
Legal DevelopmentsCorporations Accused of Allowing Excess NDMA in Zantac MDL
James Parker · March 4, 2020
A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.
Legal DevelopmentsCanada Faces a Zantac Alternatives Shortage
Benjamin Duong · February 11, 2020
Canada is facing shortages of heartburn medications after a Zantac recall led to an increase in demand for alternatives.
NewsBoynton Beach Zantac Lawsuit Filed by Local Woman
James Parker · January 15, 2020
A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.
Legal DevelopmentsExposure to Heat During Storage Causes Zantac Contamination
Benjamin Duong · January 14, 2020
Heat is the culprit causing carcinogenic NDMA contamination in Zantac, according to recent testing by Emery Pharma. A citizen petition requesting a total suspension of ranitidine products has been submitted to the FDA.
NewsMore Companies Pull Heartburn Meds to Participate in FDA Ranitidine Recall
James Parker · January 13, 2020
Appco Pharma and Denton Pharma have voluntarily recalled generic versions of Zantac (ranitidine) to align with the FDA's efforts to remove drugs from circulation that may contain more than 96 nanograms of NDMA per million nanograms of ranitidine.
FDA Regulation5 Alternatives to Zantac
Benjamin Duong · January 7, 2020
What are the alternative options to treat heartburn and related conditions? Here are 5 medications to take instead of Zantac.
Health Features